Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Two injections of mRNA-1273, a lipid nanoparticle–encapsulated mRNA-based vaccine produced in collaboration with the NIAID that encodes the SARS-CoV-2 spike protein, conferred protection against Covid-19 illness in 94% of vaccinated patients. Adverse effects of the vaccine were mild, transient local...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2021-02, Vol.384 (5), p.403-416 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 416 |
---|---|
container_issue | 5 |
container_start_page | 403 |
container_title | The New England journal of medicine |
container_volume | 384 |
creator | Baden, Lindsey R El Sahly, Hana M Essink, Brandon Kotloff, Karen Frey, Sharon Novak, Rick Diemert, David Spector, Stephen A Rouphael, Nadine Creech, C. Buddy McGettigan, John Khetan, Shishir Segall, Nathan Solis, Joel Brosz, Adam Fierro, Carlos Schwartz, Howard Neuzil, Kathleen Corey, Larry Gilbert, Peter Janes, Holly Follmann, Dean Marovich, Mary Mascola, John Polakowski, Laura Ledgerwood, Julie Graham, Barney S Bennett, Hamilton Pajon, Rolando Knightly, Conor Leav, Brett Deng, Weiping Zhou, Honghong Han, Shu Ivarsson, Melanie Miller, Jacqueline Zaks, Tal |
description | Two injections of mRNA-1273, a lipid nanoparticle–encapsulated mRNA-based vaccine produced in collaboration with the NIAID that encodes the SARS-CoV-2 spike protein, conferred protection against Covid-19 illness in 94% of vaccinated patients. Adverse effects of the vaccine were mild, transient local reactions, and the incidence of systemic effects such as fever, headache, and fatigue was low. |
doi_str_mv | 10.1056/NEJMoa2035389 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7787219</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2486179867</sourcerecordid><originalsourceid>FETCH-LOGICAL-c627t-c38af8980440698f7abc4e8e744890d4f74c00c0a3b623c5a362a5d2800a8d0a3</originalsourceid><addsrcrecordid>eNp1kEtLw0AURgdRbK0u3UpAXI7eeWQeG6GU-qJWaLXbYTqZsSlNUpNU6L83pbXYhbO5MPdw7seH0CWBWwKxuBv2X14LS4HFTOkj1CYxY5hzEMeoDUAV5lKzFjqrqjk0j3B9ilqMMakE6DaS_RBSZ906snkSjW3w9ToqQlTPfJSNhl1MqGTRuDsa414xwTSaWOfS3J-jk2AXlb_YzQ76eOi_957w4O3xudcdYCeorLFjygalFWwSaRWknTrulZecKw0JD5I7AAeWTQVlLrZMUBsnVAFYlTTfHXS_9S5X08wnzud1aRdmWaaZLdemsKk53OTpzHwW30ZKJSnRjeB6JyiLr5WvajMvVmXeZDaUK0GkVkI2FN5SriyqqvRhf4GA2fRsDnpu-Ku_sfb0b7ENcLMFsqwyuZ9n_4h-AIChgKY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2486179867</pqid></control><display><type>article</type><title>Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>New England Journal of Medicine</source><creator>Baden, Lindsey R ; El Sahly, Hana M ; Essink, Brandon ; Kotloff, Karen ; Frey, Sharon ; Novak, Rick ; Diemert, David ; Spector, Stephen A ; Rouphael, Nadine ; Creech, C. Buddy ; McGettigan, John ; Khetan, Shishir ; Segall, Nathan ; Solis, Joel ; Brosz, Adam ; Fierro, Carlos ; Schwartz, Howard ; Neuzil, Kathleen ; Corey, Larry ; Gilbert, Peter ; Janes, Holly ; Follmann, Dean ; Marovich, Mary ; Mascola, John ; Polakowski, Laura ; Ledgerwood, Julie ; Graham, Barney S ; Bennett, Hamilton ; Pajon, Rolando ; Knightly, Conor ; Leav, Brett ; Deng, Weiping ; Zhou, Honghong ; Han, Shu ; Ivarsson, Melanie ; Miller, Jacqueline ; Zaks, Tal</creator><creatorcontrib>Baden, Lindsey R ; El Sahly, Hana M ; Essink, Brandon ; Kotloff, Karen ; Frey, Sharon ; Novak, Rick ; Diemert, David ; Spector, Stephen A ; Rouphael, Nadine ; Creech, C. Buddy ; McGettigan, John ; Khetan, Shishir ; Segall, Nathan ; Solis, Joel ; Brosz, Adam ; Fierro, Carlos ; Schwartz, Howard ; Neuzil, Kathleen ; Corey, Larry ; Gilbert, Peter ; Janes, Holly ; Follmann, Dean ; Marovich, Mary ; Mascola, John ; Polakowski, Laura ; Ledgerwood, Julie ; Graham, Barney S ; Bennett, Hamilton ; Pajon, Rolando ; Knightly, Conor ; Leav, Brett ; Deng, Weiping ; Zhou, Honghong ; Han, Shu ; Ivarsson, Melanie ; Miller, Jacqueline ; Zaks, Tal ; COVE Study Group</creatorcontrib><description>Two injections of mRNA-1273, a lipid nanoparticle–encapsulated mRNA-based vaccine produced in collaboration with the NIAID that encodes the SARS-CoV-2 spike protein, conferred protection against Covid-19 illness in 94% of vaccinated patients. Adverse effects of the vaccine were mild, transient local reactions, and the incidence of systemic effects such as fever, headache, and fatigue was low.</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa2035389</identifier><identifier>PMID: 33378609</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>2019-nCoV Vaccine mRNA-1273 ; Adolescent ; Adult ; Adverse events ; Age ; Aged ; Allergies ; Cardiovascular disease ; Coronaviridae ; Coronaviruses ; COVID-19 ; COVID-19 - diagnosis ; COVID-19 - immunology ; COVID-19 - prevention & control ; COVID-19 Vaccines - adverse effects ; COVID-19 Vaccines - immunology ; Disease prevention ; Disease transmission ; Drug dosages ; Drug stores ; Enrollments ; Female ; Humans ; Incidence ; Infections ; Infectious diseases ; Male ; Middle Aged ; mRNA ; Nanoparticles ; Original ; Patient Acuity ; Placebos ; R&D ; Research & development ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Single-Blind Method ; Spike Glycoprotein, Coronavirus ; Spike protein ; Treatment Outcome ; Vaccine efficacy ; Vaccines ; Young Adult</subject><ispartof>The New England journal of medicine, 2021-02, Vol.384 (5), p.403-416</ispartof><rights>Copyright © 2020 Massachusetts Medical Society. All rights reserved.</rights><rights>Copyright © 2020 Massachusetts Medical Society.</rights><rights>Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c627t-c38af8980440698f7abc4e8e744890d4f74c00c0a3b623c5a362a5d2800a8d0a3</citedby><cites>FETCH-LOGICAL-c627t-c38af8980440698f7abc4e8e744890d4f74c00c0a3b623c5a362a5d2800a8d0a3</cites><orcidid>0000-0003-0489-0074 ; 0000-0002-2179-2436</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa2035389$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMoa2035389$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>230,314,776,780,881,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33378609$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baden, Lindsey R</creatorcontrib><creatorcontrib>El Sahly, Hana M</creatorcontrib><creatorcontrib>Essink, Brandon</creatorcontrib><creatorcontrib>Kotloff, Karen</creatorcontrib><creatorcontrib>Frey, Sharon</creatorcontrib><creatorcontrib>Novak, Rick</creatorcontrib><creatorcontrib>Diemert, David</creatorcontrib><creatorcontrib>Spector, Stephen A</creatorcontrib><creatorcontrib>Rouphael, Nadine</creatorcontrib><creatorcontrib>Creech, C. Buddy</creatorcontrib><creatorcontrib>McGettigan, John</creatorcontrib><creatorcontrib>Khetan, Shishir</creatorcontrib><creatorcontrib>Segall, Nathan</creatorcontrib><creatorcontrib>Solis, Joel</creatorcontrib><creatorcontrib>Brosz, Adam</creatorcontrib><creatorcontrib>Fierro, Carlos</creatorcontrib><creatorcontrib>Schwartz, Howard</creatorcontrib><creatorcontrib>Neuzil, Kathleen</creatorcontrib><creatorcontrib>Corey, Larry</creatorcontrib><creatorcontrib>Gilbert, Peter</creatorcontrib><creatorcontrib>Janes, Holly</creatorcontrib><creatorcontrib>Follmann, Dean</creatorcontrib><creatorcontrib>Marovich, Mary</creatorcontrib><creatorcontrib>Mascola, John</creatorcontrib><creatorcontrib>Polakowski, Laura</creatorcontrib><creatorcontrib>Ledgerwood, Julie</creatorcontrib><creatorcontrib>Graham, Barney S</creatorcontrib><creatorcontrib>Bennett, Hamilton</creatorcontrib><creatorcontrib>Pajon, Rolando</creatorcontrib><creatorcontrib>Knightly, Conor</creatorcontrib><creatorcontrib>Leav, Brett</creatorcontrib><creatorcontrib>Deng, Weiping</creatorcontrib><creatorcontrib>Zhou, Honghong</creatorcontrib><creatorcontrib>Han, Shu</creatorcontrib><creatorcontrib>Ivarsson, Melanie</creatorcontrib><creatorcontrib>Miller, Jacqueline</creatorcontrib><creatorcontrib>Zaks, Tal</creatorcontrib><creatorcontrib>COVE Study Group</creatorcontrib><title>Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Two injections of mRNA-1273, a lipid nanoparticle–encapsulated mRNA-based vaccine produced in collaboration with the NIAID that encodes the SARS-CoV-2 spike protein, conferred protection against Covid-19 illness in 94% of vaccinated patients. Adverse effects of the vaccine were mild, transient local reactions, and the incidence of systemic effects such as fever, headache, and fatigue was low.</description><subject>2019-nCoV Vaccine mRNA-1273</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Adverse events</subject><subject>Age</subject><subject>Aged</subject><subject>Allergies</subject><subject>Cardiovascular disease</subject><subject>Coronaviridae</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - immunology</subject><subject>COVID-19 - prevention & control</subject><subject>COVID-19 Vaccines - adverse effects</subject><subject>COVID-19 Vaccines - immunology</subject><subject>Disease prevention</subject><subject>Disease transmission</subject><subject>Drug dosages</subject><subject>Drug stores</subject><subject>Enrollments</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Middle Aged</subject><subject>mRNA</subject><subject>Nanoparticles</subject><subject>Original</subject><subject>Patient Acuity</subject><subject>Placebos</subject><subject>R&D</subject><subject>Research & development</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Single-Blind Method</subject><subject>Spike Glycoprotein, Coronavirus</subject><subject>Spike protein</subject><subject>Treatment Outcome</subject><subject>Vaccine efficacy</subject><subject>Vaccines</subject><subject>Young Adult</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kEtLw0AURgdRbK0u3UpAXI7eeWQeG6GU-qJWaLXbYTqZsSlNUpNU6L83pbXYhbO5MPdw7seH0CWBWwKxuBv2X14LS4HFTOkj1CYxY5hzEMeoDUAV5lKzFjqrqjk0j3B9ilqMMakE6DaS_RBSZ906snkSjW3w9ToqQlTPfJSNhl1MqGTRuDsa414xwTSaWOfS3J-jk2AXlb_YzQ76eOi_957w4O3xudcdYCeorLFjygalFWwSaRWknTrulZecKw0JD5I7AAeWTQVlLrZMUBsnVAFYlTTfHXS_9S5X08wnzud1aRdmWaaZLdemsKk53OTpzHwW30ZKJSnRjeB6JyiLr5WvajMvVmXeZDaUK0GkVkI2FN5SriyqqvRhf4GA2fRsDnpu-Ku_sfb0b7ENcLMFsqwyuZ9n_4h-AIChgKY</recordid><startdate>20210204</startdate><enddate>20210204</enddate><creator>Baden, Lindsey R</creator><creator>El Sahly, Hana M</creator><creator>Essink, Brandon</creator><creator>Kotloff, Karen</creator><creator>Frey, Sharon</creator><creator>Novak, Rick</creator><creator>Diemert, David</creator><creator>Spector, Stephen A</creator><creator>Rouphael, Nadine</creator><creator>Creech, C. Buddy</creator><creator>McGettigan, John</creator><creator>Khetan, Shishir</creator><creator>Segall, Nathan</creator><creator>Solis, Joel</creator><creator>Brosz, Adam</creator><creator>Fierro, Carlos</creator><creator>Schwartz, Howard</creator><creator>Neuzil, Kathleen</creator><creator>Corey, Larry</creator><creator>Gilbert, Peter</creator><creator>Janes, Holly</creator><creator>Follmann, Dean</creator><creator>Marovich, Mary</creator><creator>Mascola, John</creator><creator>Polakowski, Laura</creator><creator>Ledgerwood, Julie</creator><creator>Graham, Barney S</creator><creator>Bennett, Hamilton</creator><creator>Pajon, Rolando</creator><creator>Knightly, Conor</creator><creator>Leav, Brett</creator><creator>Deng, Weiping</creator><creator>Zhou, Honghong</creator><creator>Han, Shu</creator><creator>Ivarsson, Melanie</creator><creator>Miller, Jacqueline</creator><creator>Zaks, Tal</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0489-0074</orcidid><orcidid>https://orcid.org/0000-0002-2179-2436</orcidid></search><sort><creationdate>20210204</creationdate><title>Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine</title><author>Baden, Lindsey R ; El Sahly, Hana M ; Essink, Brandon ; Kotloff, Karen ; Frey, Sharon ; Novak, Rick ; Diemert, David ; Spector, Stephen A ; Rouphael, Nadine ; Creech, C. Buddy ; McGettigan, John ; Khetan, Shishir ; Segall, Nathan ; Solis, Joel ; Brosz, Adam ; Fierro, Carlos ; Schwartz, Howard ; Neuzil, Kathleen ; Corey, Larry ; Gilbert, Peter ; Janes, Holly ; Follmann, Dean ; Marovich, Mary ; Mascola, John ; Polakowski, Laura ; Ledgerwood, Julie ; Graham, Barney S ; Bennett, Hamilton ; Pajon, Rolando ; Knightly, Conor ; Leav, Brett ; Deng, Weiping ; Zhou, Honghong ; Han, Shu ; Ivarsson, Melanie ; Miller, Jacqueline ; Zaks, Tal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c627t-c38af8980440698f7abc4e8e744890d4f74c00c0a3b623c5a362a5d2800a8d0a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>2019-nCoV Vaccine mRNA-1273</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Adverse events</topic><topic>Age</topic><topic>Aged</topic><topic>Allergies</topic><topic>Cardiovascular disease</topic><topic>Coronaviridae</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - immunology</topic><topic>COVID-19 - prevention & control</topic><topic>COVID-19 Vaccines - adverse effects</topic><topic>COVID-19 Vaccines - immunology</topic><topic>Disease prevention</topic><topic>Disease transmission</topic><topic>Drug dosages</topic><topic>Drug stores</topic><topic>Enrollments</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Middle Aged</topic><topic>mRNA</topic><topic>Nanoparticles</topic><topic>Original</topic><topic>Patient Acuity</topic><topic>Placebos</topic><topic>R&D</topic><topic>Research & development</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Single-Blind Method</topic><topic>Spike Glycoprotein, Coronavirus</topic><topic>Spike protein</topic><topic>Treatment Outcome</topic><topic>Vaccine efficacy</topic><topic>Vaccines</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baden, Lindsey R</creatorcontrib><creatorcontrib>El Sahly, Hana M</creatorcontrib><creatorcontrib>Essink, Brandon</creatorcontrib><creatorcontrib>Kotloff, Karen</creatorcontrib><creatorcontrib>Frey, Sharon</creatorcontrib><creatorcontrib>Novak, Rick</creatorcontrib><creatorcontrib>Diemert, David</creatorcontrib><creatorcontrib>Spector, Stephen A</creatorcontrib><creatorcontrib>Rouphael, Nadine</creatorcontrib><creatorcontrib>Creech, C. Buddy</creatorcontrib><creatorcontrib>McGettigan, John</creatorcontrib><creatorcontrib>Khetan, Shishir</creatorcontrib><creatorcontrib>Segall, Nathan</creatorcontrib><creatorcontrib>Solis, Joel</creatorcontrib><creatorcontrib>Brosz, Adam</creatorcontrib><creatorcontrib>Fierro, Carlos</creatorcontrib><creatorcontrib>Schwartz, Howard</creatorcontrib><creatorcontrib>Neuzil, Kathleen</creatorcontrib><creatorcontrib>Corey, Larry</creatorcontrib><creatorcontrib>Gilbert, Peter</creatorcontrib><creatorcontrib>Janes, Holly</creatorcontrib><creatorcontrib>Follmann, Dean</creatorcontrib><creatorcontrib>Marovich, Mary</creatorcontrib><creatorcontrib>Mascola, John</creatorcontrib><creatorcontrib>Polakowski, Laura</creatorcontrib><creatorcontrib>Ledgerwood, Julie</creatorcontrib><creatorcontrib>Graham, Barney S</creatorcontrib><creatorcontrib>Bennett, Hamilton</creatorcontrib><creatorcontrib>Pajon, Rolando</creatorcontrib><creatorcontrib>Knightly, Conor</creatorcontrib><creatorcontrib>Leav, Brett</creatorcontrib><creatorcontrib>Deng, Weiping</creatorcontrib><creatorcontrib>Zhou, Honghong</creatorcontrib><creatorcontrib>Han, Shu</creatorcontrib><creatorcontrib>Ivarsson, Melanie</creatorcontrib><creatorcontrib>Miller, Jacqueline</creatorcontrib><creatorcontrib>Zaks, Tal</creatorcontrib><creatorcontrib>COVE Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baden, Lindsey R</au><au>El Sahly, Hana M</au><au>Essink, Brandon</au><au>Kotloff, Karen</au><au>Frey, Sharon</au><au>Novak, Rick</au><au>Diemert, David</au><au>Spector, Stephen A</au><au>Rouphael, Nadine</au><au>Creech, C. Buddy</au><au>McGettigan, John</au><au>Khetan, Shishir</au><au>Segall, Nathan</au><au>Solis, Joel</au><au>Brosz, Adam</au><au>Fierro, Carlos</au><au>Schwartz, Howard</au><au>Neuzil, Kathleen</au><au>Corey, Larry</au><au>Gilbert, Peter</au><au>Janes, Holly</au><au>Follmann, Dean</au><au>Marovich, Mary</au><au>Mascola, John</au><au>Polakowski, Laura</au><au>Ledgerwood, Julie</au><au>Graham, Barney S</au><au>Bennett, Hamilton</au><au>Pajon, Rolando</au><au>Knightly, Conor</au><au>Leav, Brett</au><au>Deng, Weiping</au><au>Zhou, Honghong</au><au>Han, Shu</au><au>Ivarsson, Melanie</au><au>Miller, Jacqueline</au><au>Zaks, Tal</au><aucorp>COVE Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2021-02-04</date><risdate>2021</risdate><volume>384</volume><issue>5</issue><spage>403</spage><epage>416</epage><pages>403-416</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>Two injections of mRNA-1273, a lipid nanoparticle–encapsulated mRNA-based vaccine produced in collaboration with the NIAID that encodes the SARS-CoV-2 spike protein, conferred protection against Covid-19 illness in 94% of vaccinated patients. Adverse effects of the vaccine were mild, transient local reactions, and the incidence of systemic effects such as fever, headache, and fatigue was low.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>33378609</pmid><doi>10.1056/NEJMoa2035389</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-0489-0074</orcidid><orcidid>https://orcid.org/0000-0002-2179-2436</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-4793 |
ispartof | The New England journal of medicine, 2021-02, Vol.384 (5), p.403-416 |
issn | 0028-4793 1533-4406 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7787219 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; New England Journal of Medicine |
subjects | 2019-nCoV Vaccine mRNA-1273 Adolescent Adult Adverse events Age Aged Allergies Cardiovascular disease Coronaviridae Coronaviruses COVID-19 COVID-19 - diagnosis COVID-19 - immunology COVID-19 - prevention & control COVID-19 Vaccines - adverse effects COVID-19 Vaccines - immunology Disease prevention Disease transmission Drug dosages Drug stores Enrollments Female Humans Incidence Infections Infectious diseases Male Middle Aged mRNA Nanoparticles Original Patient Acuity Placebos R&D Research & development SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Single-Blind Method Spike Glycoprotein, Coronavirus Spike protein Treatment Outcome Vaccine efficacy Vaccines Young Adult |
title | Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T13%3A55%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20Safety%20of%20the%20mRNA-1273%20SARS-CoV-2%20Vaccine&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Baden,%20Lindsey%20R&rft.aucorp=COVE%20Study%20Group&rft.date=2021-02-04&rft.volume=384&rft.issue=5&rft.spage=403&rft.epage=416&rft.pages=403-416&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMoa2035389&rft_dat=%3Cproquest_pubme%3E2486179867%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2486179867&rft_id=info:pmid/33378609&rfr_iscdi=true |